Latest News and Press Releases
Want to stay updated on the latest news?
-
BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following information...
-
New York, Aug. 05, 2019 (GLOBE NEWSWIRE) -- On June 20th, 2019, EXR and a stellar consortium of partners announced their plans to launch EXR, a new stable digital asset, to be governed by a...
-
New York, Aug. 05, 2019 (GLOBE NEWSWIRE) -- On June 20th, 2019, EXR and a stellar consortium of partners announced their plans to launch EXR, a new stable digital asset, to be governed by a...
-
Cyclone® 70 will be used as a high energy, high intensity proton “driver” for a large science project for rare isotopes Louvain-la-Neuve, Belgium 5th 2019 - IBA (Ion Beam Applications S.A.,...
-
LONDON, 05 Aug. 2019 (GLOBE NEWSWIRE) -- This is the Start of Day Message for GlobeNewswire. GlobeNewswire is operated by West Corporation and is designated by the FCA as an approved primary...
-
The fleet utilisation rate in the second quarter of 2019 was 71.6 per cent (Q2 2018: 45.8 per cent), up from 62.5 per cent in the last quarter and at its highest since Q3 2015. Safe Scandinavia...
-
IMvigor130 is the first positive Phase III study of a cancer immunotherapy combination in previously untreated advanced bladder cancer Data will be shared with health authorities globally, including...
-
Belimo increased its sales by 9.3 percent to CHF 355.2 million in the first half-year 2019. On a currency-adjusted basis, this corresponds to a growth of 9.9 percent. Operating income before...
-
Regulated informationNazareth (Belgium)/Rotterdam (Netherlands), 5 August 2019 Turnover increase of 10.6%; REBITDA increased to €55.6 million Acquisitions strengthen market position in Latin...
-
Geneva, Switzerland and Boston, MA – August 5, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage biopharmaceutical company focused on the development and commercialization of...